Stocks and Investing
Stocks and Investing
Fri, November 4, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tejas Savant Maintained (TXG) at Buy with Decreased Target to $64 on, Nov 4th, 2022
Tejas Savant of Morgan Stanley, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $70 to $64 on, Nov 4th, 2022.
Tejas has made no other calls on TXG in the last 4 months.
There are 5 other peers that have a rating on TXG. Out of the 5 peers that are also analyzing TXG, 2 agree with Tejas's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Weinstein of "William Blair" Downgraded from Buy to Hold on, Friday, July 15th, 2022
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $60 on, Thursday, July 14th, 2022
These are the ratings of the 3 analyists that currently disagree with Tejas
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $25 on, Thursday, October 13th, 2022
- Dan Brennan of "Cowen & Co." Maintained at Buy with Decreased Target to $50 on, Friday, July 15th, 2022
- Derik De Bruin of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $35 on, Friday, July 15th, 2022
Contributing Sources